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Abstract
Background: Acute exposure to elevated levels of environmental particulate matter (PM) is associated with
increasing morbidity and mortality rates. These adverse health effects, e.g. culminating in respiratory and
cardiovascular diseases, have been demonstrated by a multitude of epidemiological studies. However, the
underlying mechanisms relevant for toxicity are not completely understood. Especially the role of particle-induced
reactive oxygen species (ROS), oxidative stress and inflammatory responses is of particular interest.
In this in vitro study we examined the influence of particle-generated ROS on signalling pathways leading to
activation of the arachidonic acid (AA) cascade. Incinerator fly ash particles (MAF02) were used as a model for real-
life combustion-derived particulate matter. As macrophages, besides epithelial cells, are the major targets of
particle actions in the lung murine RAW264.7 macrophages and primary human macrophages were investigated.
Results: The interaction of fly ash particles with macrophages induced both the generation of ROS and as part of
the cellular inflammatory responses a dose- and time-dependent increase of free AA, prostaglandin E2/
thromboxane B2 (PGE2/TXB2), and 8-isoprostane, a non-enzymatically formed oxidation product of AA. Additionally,
increased phosphorylation of the mitogen-activated protein kinases (MAPK) JNK1/2, p38 and ERK1/2 was observed,
the latter of which was shown to be involved in MAF02-generated AA mobilization and phosphorylation of the
cytosolic phospolipase A2. Using specific inhibitors for the different phospolipase A2 isoforms the MAF02-induced
AA liberation was shown to be dependent on the cytosolic phospholipase A2, but not on the secretory and
calcium-independent phospholipase A2. The initiation of the AA pathway due to MAF02 particle exposure was
demonstrated to depend on the formation of ROS since the presence of the antioxidant N-acetyl-cysteine (NAC)
prevented the MAF02-mediated enhancement of free AA, the subsequent conversion to PGE2/TXB2 via the
induction of COX-2 and the ERK1/2 and JNK1/2 phosphorylation. Finally we showed that the particle-induced
formation of ROS, liberation of AA and PGE2/TXB2 together with the phosphorylation of ERK1/2 and JNK1/2
proteins was decreased after pre-treatment of macrophages with the metal chelator deferoxamine mesylate (DFO).
Conclusions: These results indicate that one of the primary mechanism initiating inflammatory processes by
incinerator fly ash particles seems to be the metal-mediated generation of ROS, which triggers via the MAPK
cascade the activation of AA signalling pathway.
Background
Over the last decades a multitude of epidemiological
studies could correlate elevated levels of environmental
particulate matter (PM) with increasing cardiorespira-
tory morbidity and mortality rates [1,2], predominantly
in susceptible individuals or humans with pre-existing
pulmonary or cardiovascular diseases [3-6]. Inflamma-
tion is considered as a major factor contributing to
adverse health effects in response to elevated concentra-
tions of ambient PM and nanoparticles [7-10]. Further-
more, the respiratory and systemic inflammatory effects
have been associated with the induction of oxidative
stress [11,12].
Alveolar macrophages, besides epithelial cells, are the
major targets of particle actions in the lung and play a
key role in particle-induced inflammation and lung dis-
eases. Thus, it has been shown in vitro that bronchial
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interleukin (IL)-8, and tumor necrosis factor-a (TNF-a)
in response to respirable particles [13-16]. In addition,
treatment of monocytes and macrophages with PM
results in an increased liberation of arachidonic acid and
enhances formation of inflammatory mediators [17-19].
Arachidonic acid (AA) released from membrane phos-
pholipids by phospholipases A2 (PLA2)s e r v e sa st h e
precursor for a family of lipid mediators formed by
oxygenation through the cyclooxygenase (COX) and
lipoxygenase (LOX) pathways. The generation of lipid
mediators, also called eicosanoids, plays a central role in
cellular homeostasis, host defense and inflammatory
processes. Therefore, a deregulation of AA metabolism
can lead to the development of many oxidative stress
related diseases such as pulmonary fibrosis and lung
cancer [20-23]. Oxidants such as H2O2 have been
reported to trigger AA release and its metabolism, invol-
ving multiple enzymes and pathways [24-26]. In this
context, various studies revealed, that particles trigger
the generation of reactive oxygen species and oxidative
stress, resulting in an increased production of inflamma-
tory mediators [27,28]. Brown and colleagues [29]
demonstrated in primary alveolar macrophages and
human monocytes that exposure to ultrafine carbon
black particles triggers nuclear translocation of the tran-
scription factor NF-Ba sw e l la sa ni n c r e a s e dT N F - a
protein release, two responses which were reduced by
the antioxidant nacystelin (NAL). In addition, the anti-
oxidant N-acetyl-cysteine (NAC) also suppressed the
cyclooxygenase-2 (COX-2) induction, prostaglandin E2
(PGE2) synthesis and activation of the transcription fac-
tor NF-B by organic components of combustion
derived particles, emphasizing the important role of
ROS in particle-mediated inflammation [30]. Several stu-
dies supported an influence of transition metals, which
are abundant constituents of ambient particulate matter,
in mediating particle-induced formation of ROS [31].
Voelkel et al. [32] demonstrated a protective effect of
the metal chelator DFO on fly-ash-induced formation of
ROS. Furthermore, human studies have shown that the
instillation of extracts of PM with a high metal content
induced a stronger influx of inflammatory cells com-
pared with particles with smaller metal content [33].
Recently, Beck-Speier et al.[ 3 4 ]r e p o r t e dt h a te x t r a -
cellularly insoluble Fe2O3 particles are partly soluble
intracellularly which modulates the particle-mediated
IL-6 and PGE2 release in vitro and in vivo. This demon-
strates that even small amounts of bioavailable metals
are able to activate inflammatory processes including
the arachidonic acid cascade.
In a previous study we used the fly ash MAF02 origi-
nating from a municipal waste incinerator facility as a
model for real-life combustion-derived particulate
matter (PM) to study the in vitro responses in
RAW264.7 macrophages [17]. We have shown that
MAF02 particles induced an increased mobilization
of AA and enhanced expression of COX-2 protein.
Furthermore, the fly ash-induced AA mobilization was
shown to be dependent on activation of the mitogen-
activated protein kinases (MAPKs) ERK1/2 and to a les-
ser extent on p38. These processes were accompanied
by the intracellular formation of ROS which resulted in
the upregulation of various oxidative stress markers
such as the increase of the cellular glutathione (GSH)
content and the induction of the antioxidative enzyme
heme oxygenase-1 (HO-1). The main focus of the pre-
sent study was to elucidate the role of ROS in the acti-
vation of AA cascade in macrophages, and to examine
which constituents of MAF02 particles are responsible
for the cellular effects.
Our results revealed that exposure to MAF02 parti-
cles induces an activation of the arachidonic acid cas-
cade in the murine macrophage cell line RAW264.7 as
well as in human primary monocyte-derived macro-
phages (MDM) which was correlated with particle
uptake into the cells. Particle-induced mobilization of
AA requires the activation of ERK1/2 and is mediated
through the activation of the cytosolic phospholipase
A2 (cPLA2). Furthermore, initiation of the AA cascade
is dependent on the formation of ROS. Analysis of the
signalling pathways demonstrated that pre-treatment of
macrophages with the antioxidant NAC leads to a sig-
nificantly reduced mobilization of AA accompanied by
a decreased activation of the ERK1/2 and JNK1/2 path-
ways as well as reduced induction of COX-2 and
release of inflammatory lipid mediators. In addition,
the metal chelator DFO prevented the MAF02-induced
generation of ROS, the activation of downstream
MAPK signalling and the arachidonic acid cascade. In
summary, these data provide evidence for the involve-
ment of metal-derived ROS formation in mediating
particle-induced initiation of the inflammatory arachi-
donic acid cascade.
Results
Particle characterization
The MAF02 fly ash particles used in this study as a
model for combustion-derived PM are composed of a
large number of components. The water-soluble fraction
of MAF02 was determined to 61% by weight when
extracted with deionised water. Elemental analysis
revealed that the major components of MAF02 were Na,
K, and Ca which mainly occur as water-soluble salts
(chlorides and sulphates). The major trace metals in
MAF02 fly ash were Zn, Pb and Fe which amount to
15.2, 5.1 and 1.7% of weight, respectively. 63% of Zn,
81% of Pb and 87% of Fe were not extractable with
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analysis of the particle size distribution by scanning
mobility particle sizing (SMPS) after resuspension in air
showed that the number concentration was dominated
by fine and ultrafine particles with a modal value of 165
nm [13]. Additional analyses using a light scattering
spectrometer detecting the particle sizes up to 10 μm
(PCS-2000) and scanning electronic microscopy (SEM)
of deposited particles confirmed the low percentage of
large agglomerates (Figure 1A-B).
Uptake of fly ash particles
In order to examine the uptake and cellular distribution
of MAF02 particles in macrophages, transmission elec-
tron microscopy (TEM) images of murine RAW264.7
cells, incubated with 50 μg/ml (10.4 μg/cm
2) fly ash par-
ticles, were analyzed. TEM analysis demonstrated that
MAF02 fly ash particles were taken up by RAW264.7
macrophages in dependence of time within the exposure
period of 1 h up to 5 h (Figure 1C-F). The images
present single and agglomerated particles in the
intracellular space. Some are surrounded by a mem-
brane, others not. No particles were observed within
mitochondria or nuclei.
Viability and ROS production in fly-ash treated RAW264.7
cells in comparison to human MDM
The dose-response curves of the effects of MAF02 parti-
cles on the viability and the intracellular ROS formation
of RAW264.7 macrophages are published in Fritsch et
al. [17]. To determine whether the transformed murine
macrophage cell line represents an appropriate in vitro
model system, we compared the dose-response curves
to those obtained with human monocyte-derived macro-
p h a g e s( M D M ) .A ss h o w ni nF i g u r e2t h em u r i n ec e l l
line RAW264.7 responds similar to MDM when exposed
to MAF02 particles and therefore seems to be a proper
model system. For the experiments presented in the fol-
lowing we used a maximal MAF02 concentration of 50
μg/ml (15.6 μg/cm
2) which did not affect viability after
24 h but induced a moderate increase of intracellular
ROS levels after 3 h.
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Figure 1 Characterization and uptake of MAF02 particles. The fly ash was resuspended in filtered air, deposited on a Nuclepore™
membrane and analyzed by SEM (A). The bar indicates 2 μm. The aerosol was additionally measured by PCS-2000 light scattering spectrometer
(B). The graph is representative of three measurements. For TEM analysis RAW264.7 cells were left untreated (C) or exposed to 50 μg/ml MAF02
particles (10.4 μg/cm
2) for 1 h (D), 2.5 h (E) or 5 h (F). Representative images of three different experiments are shown. Arrows indicate MAF02
particles in agglomerates of different sizes.
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RAW264.7 cells and human MDM
AA mobilization in RAW264.7 macrophages was depen-
dent on dose and time as already shown previously [17].
To provide further evidence that RAW264.7 cells serve
as a reliable and accurate model system to investigate
particle-induced cellular inflammatory processes, we
compared the influence of MAF02 on AA mobilization
to primary human MDMs. As shown in Figure 3B, we
observed a moderate increase of AA mobilization in
M D M .H o w e v e r ,w h i l ead o s eo f5 0μg/ml (13.2 μg/
cm
2) MAF02 particles induced a 6-fold increase above
the basal level of free AA in RAW264.7 cells after 5 h, a
1.8-fold increase was observed in MDM under the same
exposure conditions. The lower potential of MAF02-
mediated AA mobilization in MDM in comparison to
RAW264.7 macrophages might be explained by a
decreased expression of the key enzyme of AA mobiliza-
tion, the cPLA2, in the primary cells compared to the
mouse cell line (data not shown).
Fly ash exposure induces the release of the AA-
derivatives PGE2/TXB2 and 8-isoprostane
Free AA can be metabolized into prostaglandins and
thromboxanes by oxygenation via the cyclooxygenase
(COX) pathway. Two isoforms of the COX have been
identified, COX-1, which is constitutively expressed, and
COX-2, which can be induced by various inflammatory
and proliferative stimuli [35,36]. Additionally, AA incor-
porated into phospholipids can be non-enzymatically
converted to isoprostanes by free radical-initiated
peroxidation.
The effect of MAF02 particles on activation of the AA
pathway prompted us to investigate whether the
increased liberation of AA is accompanied by elevated
levels of AA-metabolites. Previously we could show an
induction of COX-2 by MAF02 particles, whereas no
increase in COX-1 protein was observed (data not
shown). As shown in Figure 3C, a low dose of MAF02
at 50 μg/ml (10.4 μg/cm
2) induced a release of PGE2/
TXB2 from RAW264.7 cells in a time-dependent man-
ner up to 5 hours of exposure. Similarly, exposure to
the same concentrations and time periods led to the
release of 8-isoprostane (Figure 3D), one of the most
abundant isoprostanes, which serves as reliable biomar-
ker of oxidative stress.
Fly ash-induced liberation of arachidonic acid is regulated
by cytosolic phospholipase A2
The AA, normally incorporated at the sn-2 position of
phospholipids, can be released by activated phospholi-
pases A2 (PLA2). The protein superfamily of phospholi-
pases A2 includes the secretory (sPLA2), the cytosolic
(cPLA2), and the Ca
2+-independent PLA2 (iPLA2).
Hence the next question was which of the PLA2 are
involved in the MAF02-induced AA mobilization. To
analyze the influence of these PLA2 on MAF02-induced
AA liberation different PLA2 inhibitors were used. The
RAW264.7 macrophages were preincubated with certain
concentrations of specific inhibitors for the respective
Figure 2 MAF02 reduces the viability of human MDM and RAW264.7 macrophages and induces intracellular ROS in dependence of
dose. (A) For testing viability human MDM and RAW264.7 macrophages were treated with MAF02 particles at 10, 50, 100 and 200 μg/ml (6.3,
31.3, 62.5 and 125 μg/m
2) for 20 hours. The viability was analyzed using the WST-1 assay and results are given in percentage of untreated
controls. (B) For studying ROS formation macrophages were treated with the same particle concentrations for 3 h and subsequently loaded with
H2DCF. Induction of ROS was detected by fluorescence measurement of DCF and changes in fluorescence intensity are expressed as percentage
of untreated controls. Results are the mean ± s.e.m. of three independent experiments, each carried out in triplicate.
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μg/ml (13.2 μg/cm
2) MAF02 particles over a period of
2.5 hours (Figure 4A).
Thioetheramide-phosphatidylcholine (TEA-PC), a spe-
cific inhibitor of the sPLA2 is an analogue of phosphati-
dylcholine, containing a thioether at the sn-1 position
and an amide at the sn-2 position. Thereby it functions
as a competitive, reversible inhibitor of sPLA2 [37]. In
the experiment the preincubation with 10 μMT E A - P C
reduced the particle-induced AA mobilization to
approximately 60%, which however was not significant.
Treatment with 50 μM arachidonyltrifluoromethyl-
ketone (AACOCF3) most effectively inhibited the
MAF02-induced liberation of arachidonic acid down to
25%. AACOCF3 is a plasma membrane substrate analo-
gue of arachidonic acid [38], which blocks the catalytic
center of the cPLA2 by binding to serine reversibly. At
higher concentrations it can also inhibit the iPLA2 while
sPLA2 is not affected [39].
In order to investigate whether the iPLA2 also plays a
role in the mobilization of AA in RAW264.7 macro-
phages, bromoenol lactone (BEL) as a selective, irrever-
sible inhibitor of this enzyme was used [39]. As shown
in Figure 4A the preincubation of the cells with 5 μM
BEL had no significant influence on the particle-induced
liberation of AA in comparison to macrophages, which
were only treated with fly ash particles. Therefore it
could be excluded that the iPLA2 was involved in the
MAF02-triggered mobilization of AA. This also demon-
strates that the reduction of the MAF02-induced AA
mobilization by AACOCF3 was only due to inhibition of
the cPLA2 but not of the iPLA2.
In summary, the cytosolic PLA2 and to a minor extent
the secretory PLA2 but not the calcium-independent
Figure 3 Exposure to fly ash particles induces liberation of AA and release of PGE2 and 8-isoprostane from macrophages. RAW264.7
macrophages and human MDM, pre-labelled with [
14C]arachidonic acid, were incubated for 1, 2.5, and 5 h with MAF02 particles at 50 μg/ml
(13.2 μg/cm
2). After lipid extraction, AA and lipid mediators PGE2/TXB2 were separated by TLC (A, example of RAW264.7 cells treated for 2.5 h),
and pixel images generated by phosphoimaging were quantified by OptiQuant
® software. Semiquantitative data on AA (B) and PGE2/TXB2 (C,
only RAW264.7) liberation based on electronic autoradiographic values are expressed as percentage of control cells. (D) RAW264.7 macrophages
were incubated for 1, 2.5, and 5 h with fly ash particles at 50 μg/ml (10.4 μg/cm
2) and 8-isoprostane in the medium was determined by EIA.
Results are presented as the mean of three independent experiments and error bars represent the standard error of the mean. Statistically
significant differences from untreated control cells (*p < 0.05, **p < 0.01, *** p < 0.001). NL, neutral lipids; AA, free arachidonic acid; EICO,
eicosanoids; PL, phospholipids.
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eration of arachidonic acid.
The cPLA2 activation is mediated by its phosphory-
lation [40]. Therefore, we analyzed the phosphoryla-
tion status of cPLA2 in response to MAF02 fly ash.
Indeed, we detected an increase of the phosphory-
lated form of cPLA2 in RAW264.7 macrophages after
treatment with MAF02 particles at 50 μg/ml (15.6 μg/
cm
2) by Western blot analysis using phospho-specific
antibodies. In correlation with the inhibitor studies the
degree of cPLA2 phosphorylation increased in a time-
dependent manner from one hour to five hours of
exposure and thus paralleled the enhanced AA libera-
tion (Figure 4B).
Figure 4 MAF02-induced liberation of arachidonic acid is dependent on cPLA2. (A) RAW264.7 macrophages, pre-labelled with [
14C]
arachidonic acid, were incubated with AACOCF3 (inhibitor of cPLA2), BEL (inhibitor of iPLA2) or TEA (inhibitor of sPLA2), and subsequently treated
with 50 μg/ml MAF02 particles (13.2 μg/cm
2) for 2.5 hours. After lipid extraction, the free arachidonic acid and its metabolites were separated by
TLC, visualized by autoradiography and the optical density of the bands were analyzed by Odyssey
® software. [
14C]arachidonic acid liberation
data are expressed as percentage of untreated control cells (100%). Results are shown as the mean ± s.e.m. of three independent experiments.
*Significantly decreased compared to 50 μg/ml (13.2 μg/cm
2) MAF02-treated control cells (*p < 0.05). (B) RAW264.7 macrophages were exposed
to 50 μg/ml MAF02 particles (15.6 μg/m
2) for 1, 2.5 and 5 hours and whole cell lysates were analyzed for the phosphorylated cPLA2 protein by
Western blotting. The respective non-phosphorylated protein was used as loading control. (C) RAW264.7 macrophages were pre-incubated with
MAPK inhibitors PD98059, SB203580 and SP600125 (each 10 μM) and then exposed to 50 μg/ml MAF02 particles (15.6 μg/m
2) for 5 hours. Whole
cell lysates were analyzed for the phosphorylated cPLA2 protein, COX-2 and PCNA as loading control. The shown blots are representative of
three independent experiments.
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the MAPKs ERK1/2, JNK1/2 and p38 contribute to the
MAF02-induced cPLA2 phosphorylation. As shown in
Figure 4C, cPLA2 phosphorylation was reduced by
PD98059, an inhibitor of the upstream kinase MEK1/2
which is responsible for ERK1/2 activation and by
SB203580, an inhibitor of p38 activation. However,
SP600125, an inhibitor of JNK1/2 activation, less effi-
ciently blocked cPLA2 phosphorylation. A similar profile
was observed for the induction of MAF02-induced
expression of COX-2, which was prevented by the
MEK1/2 and the p38 inhibitor but not by the JNK1/2
inhibitor.
MAP kinases contribute to MAF02-induced AA
mobilization
Using phospho-specific antibodies we detected increased
phosphorylation of ERK1/2 and JNK1/2 after treatment
with fly ash in dependence of time, reaching its maxi-
mum after 5 hours. On the other hand, p38 MAPK was
only weakly phosphorylated after treatment of
RAW264.7 cells with MAF02 particles (Figure 5B). Only
inhibition of the ERK1/2 pathway with PD98059 lead to
a significant reduction of AA mobilization (Figure 5A)
confirming the contribution of ERK1/2 in activation of
the cPLA2 already shown in Figure 4C. The p38 and
JNK1/2 inhibitors only moderately reduced the fly ash-
mediated liberation of AA but not significantly.
Again, the primary human MDM showed a similar
time-dependent increase of ERK1/2 and JNK1/2 phos-
phorylation as well as an even stronger activation of p38
MAPK (Figure 5C).
NAC reduces fly ash-induced signalling and AA
mobilization
To explore the involvement of ROS in MAF02-mediated
AA mobilization, RAW264.7 macrophages were pre-
incubated for 30 min with the antioxidant NAC prior to
fly ash exposure. We observed in RAW264.7 macro-
phages that fly ash-induced production of ROS (Figure
6A), phosphorylation of ERK1/2 (Figure 6B), mobiliza-
tion of AA (Figure 6C) as well as COX-2 protein
expression (Figure 6D) together with the release of
PGE2/TXB2 (Figure 6E) were inhibited by 5 mM NAC
nearly completely, while 1 mM NAC had only a weak
effect on the induction of these processes. In contrary,
fly ash-induced phosphorylation of c-Jun (Figure 6F)
together with activation of JNK1/2 (data not shown)
were inhibited almost completely with only 1 mM NAC
while AA liberation is still induced and only totally
blocked at 5 mM. Together with the fact that inhibition
of JNK did not reduce AA mobilization as shown above
we conclude that JNK signalling seems not to be
involved in mobilization of AA and its metabolites. The
observed fly ash-induced activation of JNK1/2 and c-Jun
may trigger other endpoints, which were not further stu-
died. Thus, MAF02 fly ash exerts its effects via the for-
mation of ROS, which is a prerequisite for the activation
of the MAPK pathways and mobilization of AA via acti-
vation of cPLA2, and its subsequent conversion by
COX-2 to the lipid mediators PGE2/TXB2.
The water-insoluble fraction of MAF02 is responsible for
AA mobilization
To examine whether the water-soluble or insoluble frac-
tion of MAF02 are involved in the fly ash-induced acti-
vation of the AA cascade, RAW264.7 macrophages were
exposed for 2.5 h to 50 μg/ml (13.2 to 15.6 μg/cm
2)o f
the total, water-insoluble (pellet) or water-soluble
(supernatant) fraction of fly ash particles (Figure 7). We
observed that exposure of macrophages to the water-
insoluble pellet fraction of MAF02 particles induced a
marked AA and PGE2/TXB2 mobilization similar to the
liberation of AA and its metabolites in cells treated with
the total fraction of fly ash particles. In contrast, the
soluble fraction of MAF02 did not induce any significant
increase in AA and PGE2/TXB2 release, indicating that
the water-insoluble fraction of MAF02 causes the cellu-
lar particle-induced effects. In addition, while exposure
of RAW264.7 cells to the pellet fraction of fly ash
resulted in an enhanced phosphorylation of ERK1/2 and
of the transcription factor c-Jun, the supernatant frac-
tion did not activate ERK1/2 and c-Jun. These results
indicate that the metals which are still incorporated in
the glass-like matrix of the water-insoluble fraction and
probably become soluble intracellularly due to the low
pH within lysosomes are responsible for the detected
cellular events.
DFO reduces fly ash-induced signalling and AA
mobilization
Several studies have demonstrated that redox-active
metals in particular iron and zinc of ambient particulate
matter can induce an increased production of ROS
which may lead to oxidative stress. The water-insoluble
pellet fraction of MAF02 particles consists of appreci-
able amounts of zinc and iron which could cause the
generation of ROS by e.g. an iron-mediated Fenton-like
reaction. In order to investigate an association between
the metal content of MAF02 particles and activation of
the AA cascade the metal chelator DFO was added to
the RAW264.7 macrophages prior to stimulation with
fly ash particles for 2.5 h. Pre-treatment of macrophages
with DFO resulted in a decreased particle-induced
formation of ROS (Figure 8A) and prevented the
subsequent phosphorylation of the ERK1/2 MAPK
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8C) and its metabolization to PGE2/TXB2 (Figure 8D).
Phosphorylation of JNK and c-Jun was also inhibited by
DFO (Figure 8E-F). The clear inhibition of these effects
b yD F Oa sw e l la st h eo b s e r v a t i o nt h a to n l yt h ew a t e r -
insoluble fraction is responsible for the effect (Figure 7)
demonstrates that the MAF02 particles induce activation
of the AA signalling pathway by metals which are
included in the water-insoluble matrix, but which may
become bioavailable inside the cell. The effects of DFO
on the AA pathway support the hypothesis that activa-
tion of the AA cascade by fly ash particles depends on
metal-mediated ROS formation.
Discussion
Many studies detected multiple effects of PM on e.g.
inflammatory pathways in different cell types but the
challenge is to identify the key mechanisms which initi-
ate all these pleiotropic downstream responses. Here we
pinpoint the critical role of metals in PM initiated
inflammatory signalling in macrophages. In the follow-
ing we discuss the underlying mechanisms of signal
transduction and how this relates to findings observed
with other types of PM.
Our studies focused on the MAF02-induced inflamma-
tory processes with special emphasis on the regulation of
the AA metabolism. AA liberation and its metabolization
Figure 5 MAF02-induced mobilization of AA depends on ERK1/2 and MAPKs are activated in RAW264.7 macrophages as well as in
human MDM. (A) RAW264.7 cells labelled with [
14C]arachidonic acid were pre-incubated for 30 min with the indicated kinase inhibitors and
subsequently exposed to 50 μg/ml MAF02 particles (12.6 μg/cm
2) for 2.5 h. After lipid extraction, free AA was separated by TLC, visualized by
autoradiography, and the optical density of the bands were analyzed by OptiQuant
® and Odyssey
® software. [
14C]arachidonic acid mobilization
data are expressed as a percentage of the values for control cells (100% values). Results are the mean ± s.e.m. of three independent experiments
(***p < 0.001 compared to 50 μg/ml MAF02-treated cells). RAW264.7 macrophages (B) and human MDM (C) were treated with 50 μg/ml MAF02
particles (15.6 μg/m
2) for 1, 2.5 and 5 hours and whole cell lysates were analyzed for the target proteins by Western blotting. The respective
non-phosphorylated proteins are used as loading control.
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expression. (A) Adherent H2DCF-loaded RAW264.7 cells were pre-incubated with 5 mM NAC and further incubated with 10, 25, 50, 100, 200
and 300 μg/ml fly ash particles (6.3, 12.6, 31.3, 62.5, 125, 188 μg/cm
2) for 2.5 hours. Values are expressed as a percentage of the untreated
controls. For analysis of ERK1/2 (B), c-Jun (F) phosphorylation, and COX-2 expression (D), non-labelled cells were pre-incubated with NAC at 1
and/or 5 mM and further treated with 50 μg/ml MAF02 particles (15.6 μg/m
2) for 2.5 hours. Whole cell lysates were analyzed by Western
blotting. OD-band intensities of COX-2 and phospho-proteins, analyzed by Odyssey
® software, were normalized to the respective loading control
protein and expressed in relation to the maximum band intensity of the MAF02-treated sample (100%). To detect mobilization of AA and its
metabolites (C, E), RAW264.7 macrophages labelled with [
14C]arachidonic acid were pre-incubated with the antioxidant NAC at 1 or 5 mM and
subsequently exposed with 50 μg/ml MAF02 particles (13.2 μg/m
2) for 2.5 hours. After lipid extraction, the free arachidonic acid and its
metabolites were separated by TLC, visualized by autoradiography and analyzed by OptiQuant
® software. Data on AA liberation are expressed as
percentage of control cells (100% values). Results are presented as the mean ± s.e.m. of three independent experiments (* p < 0.05, **p < 0.01,
***p < 0.001 compared to 50 μg/ml MAF02-treated cells).
Fritsch-Decker et al. Particle and Fibre Toxicology 2011, 8:23
http://www.particleandfibretoxicology.com/content/8/1/23
Page 9 of 18to lipid mediators are relevant in initiation, maintenance
and resolution of inflammation and therefore play a
significant role in chronic inflammation. Furthermore,
disturbed regulation of AA metabolism may contribute to
cancer diseases in particular those of the lung [20-22].
The fly ash particles induced a strong mobilization of
AA at non-cytotoxic concentrations. For similar metal-
laden combustion-derived particles such as residual oil
fly ash (ROFA) the influence of lipid mediators in med-
iating pulmonary toxicity has been shown in vivo and
in vitro [41] pointing to deregulated lipid mediators as a
central toxicity pathway.
Human monocyte-derived macrophages (MDM) were
tested for their response to MAF02, however we only
observed a 1.8-fold increase of AA liberation after
5 hours exposure in comparison to a 6-fold increase in
RAW264.7 macrophages. The lower expression of
cPLA2 in MDM compared to RAW264.7 cells may be a
reason for their reduced potential to induce AA mobili-
zation (data not shown). Alternatively, human macro-
phages might be less susceptible to PM-induced AA
liberation, a possibility which needs to be further inves-
tigated. Although the AA mobilization after MAF02
treatment was not as pronounced as in RAW264.7
macrophages, the increase in ROS and MAPK activity as
well as the reduction in viability after exposure to
MAF02 was quite comparable to the effects observed in
RAW264.7 cells. Therefore, it seems that the signalling
cascades induced by fly ash particles in RAW264.7 cells
are conserved in primary human macrophages.
The mobilized arachidonic acid may be further meta-
bolized by cyclooxygenases (COX) to biologically active
mediators such as leukotrienes, prostaglandins and
thromboxanes, which play a role during inflammatory
processes. Here we demonstrate that MAF02-induced
COX-2 is also catalytically active since the level of the
metabolites PGE2/TXB2 in the supernatant increased in
a time-dependent manner. Particle-induced induction
of COX-2 as well as release of PGE2 by immune-
competent cells has also been shown in other studies
[18,42-44]. The consequences of increased PGE2 release
cannot be predicted directly since it regulates pro-
inflammatory as well as anti-inflammatory effects. The
action of PGE2 is dependent on the presence or absence
of PGE2 receptors EP1 - EP4 on the target cells. PGE2
has therefore the ability to switch from pro-inflamma-
tory to anti-inflammatory mechanisms. Anti-inflamma-
tory effects have been shown in human monocytes
where PGE2 down-regulated TNF-a induced expression
of ICAM-1 by interaction with EP2 and EP4 [45]. In
contrary, interaction with EP1 and EP3 induced proin-
flammatory effects. Beck-Speier et al. [46] suggest, that
PGE2 released due to fine TiO2 particles with low sur-
face area may act anti-inflammatory in that it down-reg-
ulates particle-induced inflammatory effects. However,
PGE2 released due to ultrafine TiO2 particles with large
surface area may act proinflammatory since the inflam-
matory mediator leukotriene B4 as well as release of
8-isoprostane were also induced. The basis for these
size-dependent differences remains to be clarified.
MAF02 exposure induced enhanced ROS levels as
measured by the DCF assay. However, as the DCF assay
sometimes produces false positive results [47] we ana-
lysed previously additional markers of oxidative stress
e.g. HO-1 induction and increase of GSH synthesis
[13,17]. In addition, in the present study we also
detected a significant release of 8-isoprostane, which
further demonstrates the high oxidative potential of the
particles on cell membranes. 8-isoprostane, however, has
Figure 7 The water-insoluble fraction of MAF02 is responsible
for AA mobilization and activation of ERK1/2 and c-Jun. For
analysis of ERK1/2 (A), and c-Jun (D) phosphorylation non-labelled
cells were exposed with 50 μg/ml (15.6 μg/m
2) of the total, water-
soluble and water-insoluble fraction of fly ash particles for 2.5 hours.
Whole cell lysates were analyzed by Western blotting. OD-band
intensities of phosphorylated proteins, analyzed by Odyssey
®
software, were normalized to the respective loading control protein
and expressed in relation to the maximum band intensity of the
MAF02-treated sample (100%). (B, C) RAW264.7 cells labelled with
[
14C]arachidonic acid were treated with 50 μg/ml (13.2 μg/m
2)o f
the total, water-insoluble and water-soluble fraction of fly ash
particles for 2.5 hours. After lipid extraction, the free arachidonic
acid and its metabolites were separated by TLC, visualized by
autoradiography and analyzed by OptiQuant
® and
Odyssey
®software. Data on AA liberation are expressed as
percentage of control cells (100% values). Results are presented as
the mean ± s.e.m. of three independent experiments.
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Page 10 of 18Figure 8 DFO inhibits the MAF02-induced formation of ROS, mobilization of AA, PGE2/TXB2 and phosphorylation of ERK1/2.( A )
Adherent H2DCF-loaded RAW264.7 cells were incubated with DFO before treatment with 10, 25, 50, 100, 200 and 300 μg/ml MAF02 particles
(6.3, 12.6, 31.3, 62.5, 125, 188 μg/cm
2) for 2.5 hours. Values are expressed as a percentage of the untreated controls. For analysis of ERK1/2 (B),
JNK (E), and c-Jun phosphorylation non-labelled cells were pre-incubated with various concentrations of DFO and subsequently exposed with 50
μg/ml MAF02 particles (15.6 μg/m
2) for 2.5 hours. Whole cell lysates were analyzed by Western blotting. OD-band intensities of phosphorylated
proteins, analyzed by Odyssey
® software, were normalized to the respective loading control protein and expressed in relation to the maximum
band intensity of the MAF02-treated sample (100%). [
14C]arachidonic acid-labelled RAW264.7 macrophages were treated with DFO before
exposure with 50 μg/ml MAF02 particles (13.2 μg/m
2) for 2.5 hours. After lipid extraction, the free arachidonic acid and its metabolites were
separated by TLC, visualized by autoradiography and analyzed by OptiQuant
® software. Data on AA (C) and PGE2/TXB2 (D) liberation are
expressed as percentage of control cells (100% values). Results are presented as the mean ± s.e.m. of three independent experiments (* p < 0.05,
**p < 0.01, p*** < 0.001 compared to 50 μg/ml MAF02-treated cells).
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Page 11 of 18numerous biologic effects, e.g. it is a potent vasocon-
strictor, causes contraction of bronchial smooth muscle
and induces exudation in the airways [48,49]. Therefore,
the enhanced formation of disease-related 8-isoprostane
can contribute to the adverse health effects of particu-
late matter.
In most cases, the cause of AA mobilization and gen-
eration of AA-derived lipid mediators is the activation
of phospholipase A2 which catalyzes the deacylation of
AA from the sn-2 position of membrane glyceropho-
spholipids. In this study we demonstrated that the
MAF02-induced AA mobilization is mainly mediated by
the Ca
2+-dependent cPLA2, not by iPLA2 and sPLA2.
This is supported by the finding that MAF02-induced
AA mobilization is inhibited by the intracellular calcium
chelator BAPTA/AM [17] as well as by the extracellular
calcium chelator EGTA (data not shown). An elevated
intracellular Ca
2+ concentration is necessary for the
translocation of the activated cPLA2 to its target struc-
ture in perinuclear membranes [50]. Stone and collea-
gues [51] observed an increase of the intracellular Ca
2
+-concentration in the human Mono Mac 6 cell line
after exposure to ultrafine carbon black particles, which
could also be inhibited by EGTA as well as by the cal-
cium channel blocker verapamil. The authors suggest
that ROS triggers an opening of the Ca
2+-channels
which lead to a flux from the extracellular compartment
into the cytosol [51,52].
In MAF02-treated cells cPLA2 was phosphorylated
which is required for activation of the enzyme. The time
course of phosphorylation was in accordance with the
MAF02-induced AA mobilization and could be reduced
by inhibition of the ERK1/2 and p38 MAPKs. Activation
of cPLA2 by phosphorylation via the ERK1/2 and the
p38 MAPK signalling pathways has already been
described [50]. Using phospho-specific antibodies we
found in this study that ERK1/2 and JNK1/2 were phos-
phorylated after treatment of RAW264.7 macrophages
and MDM with MAF02 particles with similar kinetic
compared to the mobilization of AA whereas p38
M A P Kw a so n l yw e a k l yp h o s p h o r y l a t e d .T h u sM A P K s
activity is not only required to activate the cPLA2 and
mobilize AA but is also induced in response to MAF02.
Similar results were found in primary canine alveolar
macrophages which were exposed to diesel exhaust par-
ticles. Inhibitor studies indicated an involvement of
ERK1/2 but not of p38 MAPK in the DEP-induced
mobilization of AA and synthesis of its metabolites
PGE2 and LTB4 [18].
The results so far indicate an involvement of ROS and
oxidative stress in the cellular responses to the fly ash
particles. To demonstrate involvement of ROS in the
AA metabolism we used the antioxidant NAC, a general
antioxidant but also a metal-binding agent [53]. NAC
has been used as a tool for investigating the role of
ROS in numerous biological and pathological processes
[54]. We could show that pre-treatment of RAW264.7
macrophages with 5 mM NAC resulted in significant
inhibition of fly ash-induced phosphorylation of
ERK1/2, mobilization of AA, and induced expression of
COX-2. This clearly demonstrates a contribution
of ROS and possibly metals in these mechanisms.
While pre-incubation of the cells with 1 mM NAC had
no or only a weak effect on these responses, surpris-
ingly the MAF02-induced phosphorylation of JNK1/2
as well as of c-Jun was completely inhibited at this low
NAC concentration. This means that the activation of
the JNK1/2 signalling pathway is, although ROS depen-
dent, probably not involved in the mechanisms of
MAF02-induced mobilization of AA, and expression of
COX-2, at least in RAW264.7 macrophages. In accor-
dance with this hypothesis, the specific inhibitor of the
JNK1/2 pathway SP600125 did not prevent AA mobili-
zation and COX induction by MAF02 thus demonstrat-
ing that indeed the JNK cascade is not involved in this
response.
The mechanisms by which endogenously produced
ROS or metals activate MAP kinases are not well
defined. One possible explanation is the regulation of
the MAPK activity by protein phosphatases, which are
known to be sensitive to ROS and metals because of
their cysteinyl thiol groups in their active site [11,55,56].
T h ef l ya s hu s e di nt h i ss t u d yh a sah i g hc o n t e n to f
water-soluble material (61% by weight) which has been
shown to be biologically inactive in our assays. This is
contrary to other studies with complex material such as
ambient particulate matter where water-soluble metals
were shown to be associated with induction of ROS, oxi-
dative stress and pro-inflammatory effects [33]. Although
transition metals such as Fe and Zn are significant com-
ponents of the MAF02 fly ash, the water-soluble portion
of these metals may be too low-concentrated to catalyze
the formation of ROS via a Fenton-like reaction
[32,57-59]. The insoluble fraction still contains metals in
a glass-like matrix and those metals on the surface may
become soluble intracellularly and thereby responsible
for the observed effects. The metal chelator DFO
prevented entirely ROS formation and downstream sig-
nalling suggesting a critical role of metals in the inflam-
matory response triggered by MAF02. Thus, in the
absence of transition metals the remaining particulate
fraction is inactive and does not trigger inflammation
mediated by AA. The relevance of biologically available
transition metals in particular iron in inducing adverse
effects has been demonstrated for air pollution particles
[60], asbestos [61], and carbon nanotubes [62].
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and the previous study we suggest the following
mechanism (Figure 9):
The MAF02 particles are taken up by RAW264.7
macrophages and induce a metal-mediated generation of
reactive oxygen species. Furthermore, release of 8-iso-
prostane, increased synthesis of glutathione and induc-
tion of heme oxygenase-1 [17] indicate significant
oxidative stress due to particle exposure resulting in an
anti-oxidative cellular response. Oxidative stress leads to
activation of the ERK1/2 pathway including MEK1/2,
JNK1/2 and p38 MAP kinases. The ERK1/2 pathway
may be activated by interference of the particles with
membrane proteins such as growth factor receptors.
Growth factor receptors and MAPK can also be stimu-
lated by inhibition of phosphatases, which are metal-
and redox-sensitive enzymes.
Active ERK1/2 and p38 leads to phosphorylation and
activation of cPLA2. The increase of the intracellular
calcium level induces the cPLA2 to translocate to the
perinuclear membranes where it catalyzes the mobiliza-
tion of AA. In addition, it is possible that ROS inhibit
the reacylation of AA, which would also lead to an
enhanced level of free AA in the cytosol. Free AA serves
as substrate for COX-2 and prostaglandin synthases
leading to the release of PGE2. Increased transcription
of COX-2 requires activation of ERK1/2 and p38, but
may also involve other pathways e.g. NF-B [63].
Conclusions
In summary, the results of the present study suggest,
that exposure of macrophages to fly ash particles pro-
motes inflammation by liberation of arachidonic acid
and metabolization to related products such as PGE2/
TXB2 via metal-induced formation of ROS and induc-
tion of cellular oxidative stress.
The fly ash-induced processes such as formation of
ROS, activation of ERK1/2, JNK1/2 and p38 MAPK
pathways were also observed in primary human
MDM, however mobilization of AA was less severe pos-
sibly because of the incomplete differentiation to
macrophages.
The postulated mechanism may therefore also be rele-
vant in humans, where it may contribute to lung dis-
eases such as chronic inflammation after acute or
chronic exposure to fine and ultrafine particulate matter.
Methods
Materials
Cell culture medium and supplements, Hank’s balanced
salt solution (HBSS) and 2’,7’-dichlorodihydrofluores-
cein-diacetate (H2DCF-DA) were obtained from Invitro-
gen (Karlsruhe, Germany). Accutase was from PAA
(Cölbe, Germany). The WST-1 reagent was from Roche
(Mannheim, Germany) and the SDS-PAGE supplies
were from Carl Roth (Karlsruhe, Germany). [1-
14C]ara-
chidonic acid (2.07 GBq/mmol) and ECL reagents were
purchased from GE Healthcare (Freiburg, Germany).
Chemicals for lipid extraction and chromatography
were from VWR International (Bruchsal, Germany). The
PLA2 inhibitors thioetheramide phosphatidylcho-
line (TEA-PC), arachidonyl trifluoromethyl ketone
(AACOCF3), and bromoenol lactone (BEL) were from
Cayman (Biozol, Eching, Germany). MAPK inhibitors,
PD98059 (2’-amino-3’-methoxyflavone), SB203580 [4-(4-
fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)
1H-imidazole], and SP600125 (1,9-pyrazoloanthrone)
were purchased from Merck (Darmstadt, Germany). N-
acetyl-cysteine (NAC), deferoxamine mesylate (DFO)
and standard laboratory chemicals were supplied by
Sigma-Aldrich (Taufkirchen, Germany). The human
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Figure 9 Scheme of the MAF02-induced activation of the
arachidonic acid cascade. The MAF02 particles are taken up by
RAW264.7 macrophages and release metal ions (Me
n+) inside the
cells which induces formation of reactive oxygen species (ROS).
Release of 8-isoprostane indicates the occurrence of oxidative stress.
Oxidative stress in turn leads to activation of the ERK1/2 and p38
pathways. The ERK1/2 pathway may be activated by interfering of the
particles with membrane proteins. On the other hand, enhanced
MAPK activation can also occur by inhibition of metal- and redox-
sensitive phosphatases, which dephosphorylate and inactivate MAPK.
Activation of ERK1/2 and p38 leads to phosphorylation and activation
of cPLA2 (cytosolic phospholipase A2). The increase of the intracellular
calcium level induces cPLA2 translocation to the perinuclear
membranes where it catalyzes the mobilization of AA. On the other
hand, it is possible that ROS inhibit the reacylation of AA, which
would also lead to an enhanced level of free AA in the cytosol. Free
AA is converted by COX-2 (cyclooxygenase-2) and prostaglandin
synthases to PGE2/TXB2 (prostaglandin E2/thromboxane B2). Increased
transcription of COX-2 requires activation of ERK1/2 and p38, but may
also involve other pathways e.g. NF-B.
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ing factor (GM-CSF) was from VWR, Bruchsal,
Germany.
Specific anti-phospho ERK1/2 (Tyr
202/Tyr
204), anti-
phospho p38 (Tyr
180/Tyr
182), anti-phospho JNK1/2
(Tyr
183/Tyr
185), anti-phospho c-Jun, anti-phospho
MEK1/2, anti-phospho cPLA2 (Ser
505), and anti-c-Jun
were obtained from Cell Signaling (New England Bio-
labs, Frankfurt, Germany). Anti-ERK1/2, anti-p38, anti-
JNK, anti-cPLA2, anti-LaminB, and anti-PCNA were
from Santa Cruz (Heidelberg, Germany). Anti-COX-1
and anti-COX-2 were from Biozol (Eching, Germany).
Horseradish peroxidase (HRP)-conjugated secondary
anti-rabbit antibodies were from GE Healthcare,
Braunschweig, Germany and anti-mouse antibodies
from DAKO (Hamburg, Germany). IRDye700 or
IRDye800 coupled secondary antibodies were obtained
from Biomol (Hamburg, Germany).
Particles
The fly ash MAF02 originates from a municipal waste
incinerator facility and was collected in 2002 by electro-
static precipitation in the exhaust gas cleaning system.
Subsequently, the powder was size-fractionated to
remove particles > 20 μm. The remaining fine fraction
(< 20 μm) has been used for the in vitro experiments.
Analysis of the particle size distribution by scanning
mobility particle sizing (SMPS, DMA 3071 with CPC
3022A, TSI Inc., Shoreview, USA) after resuspension in
air showed that the number concentration was domi-
nated by fine and ultrafine particles with a modal value
of 165 nm [13]. Additional analyses using the light-scat-
tering spectrometer PCS-2000 (Palas, Karlsruhe, Ger-
many) and scanning electronic microscopy (SEM) of
particles deposited on a Nuclepore™ Polycarbonate
Membrane (pore size 0.4 μm, Whatman, Dassel, Ger-
many) confirmed the low percentage of large agglomer-
ates (Figure 1A-B).
Elemental analysis was performed with total particles
as well as with the water-soluble and insoluble fraction.
For the separation 1 g of particles was extracted two-
fold with 25 ml of deionized water. The aqueous sus-
pensions were probe sonified (Branson Sonifier 250,
Heinemann, Schwäbisch-Gmünd, Germany) for 20 s
(duty cycle 40, output control 4) and centrifuged at
1000 g for 30 min. The combined aqueous supernatants
as well as the dried pellet were analyzed by Total Reflec-
t i o nX - r a yF l u o r e s c e n c eA n a l y s i s( T R F A ) .A sa n dC d
were measured by Inductively Coupled Plasma - Optical
Emission Spectrometry (ICP-OES). The fraction of ele-
mental carbon was determined by combustion of the
material in a copper tube at 950°C and measuring the
CO concentration.
For cell experiments stock suspensions of 10 mg/ml in
culture medium without FBS were prepared freshly and
dispersed by vortexing and probe sonication for 20 s.
Working suspensions were prepared by further dilution
in culture medium. The particles were tested for endo-
toxin content with the colorimetric Limulus Amebocyte
Lysate (LAL) assay (Lonza, Basel, Switzerland). A parti-
cle suspension of 1 mg/ml in water was centrifuged for
10 min at 20,800 g and the supernatant was analyzed
according to the instructions of the manufacturer. The
result was below the lower limit of quantification of the
test (< 0.1 EU/ml).
Cell culture
The murine RAW264.7 macrophage cell line was
obtained from the American Type Culture Collection
(ATCC Rockville, MD, USA). The cells were cultured in
DMEM supplemented with 10% fetal bovine serum
(FBS), 100 U/ml penicillin and 100 μg/ml streptomycin
in 5% CO2 at 37°C. They were passaged every 3 to 4
days by scraping off the cells from the culture plate. To
investigate AA release and intracellular signalling path-
ways, cells were seeded onto 12-well plates at 3 × 10
5
cells/well or into 6-well plates at 2.5 × 10
6 cells/well.
After adhering overnight, the cells were cultured for
another day in serum-free medium prior to stimulation.
All inhibitors were added 30 min prior to stimulation at
the indicated concentrations.
Generation of human monocyte-derived macrophages
(MDM)
Human peripheral blood mononuclear cells (PBMC)
were isolated from buffy coats derived from healthy
donors (Städtisches KlinikumK a r l s r u h e )b yF i c o l ld e n -
sity gradient centrifugation (Ficoll-Paque™ Premium,
GE Healthcare, Freiburg). For isolation of CD14-positive
monocytes, the MACS magnetic separation technique
(Miltenyi Biotec, Bergisch-Gladbach, Germany) was used
according to the manufacturer’s protocol. Briefly, 1 ×
10
7 PBMC suspended in 80 μl of MACS buffer (phos-
phate-buffered saline (PBS) containing 0.5% BSA and 2
mM EDTA) were mixed with 20 μlo fa n t i - C D 1 4
microBeads and incubated at 4°C for 15 min. The cells
were washed with 2 ml MACS buffer, resuspended in
500 μl fresh MACS buffer and loaded onto a separation
column which was positioned in a MidiMACS magnet.
Non-adherent cells were washed out and after removal
from the magnet the CD14-positive cells were recovered
from the column by pressing 5 ml of MACS buffer
through the column.
The percentage of the purified monocytes was deter-
mined by flow cytometry (LSR II with CellQuest PRO
software, Becton Dickinson, Heidelberg, Germany) using
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Krefeld, Germany) and FITC-labelled anti-IgG2a antibo-
dies (Miltenyi Biotec, Bergisch Gladbach, Germany) as
isotype control. The cells were detected with an excita-
tion wavelength of 488 nm and an emission wavelength
at 530 nm. The purity of the preparation was deter-
mined to be 89.4 ± 1.2% (n = 4) of CD14-positive
monocytes after the cell separation from different
donors. The remaining 9 - 11% cells were lymphocytes,
which were not further analyzed.
The isolated cells were resuspended in RPMI 1640
medium supplemented with 1% MEM non-essential
amino acids, 1% pyruvate, 4% FBS, 100 U/ml penicillin,
100 μg/ml streptomycin, 2 mM glutamine and 2 ng/ml
GM-CSF at 1 × 10
6 cells/ml and cultivated in 5% CO2
at 37°C for 10 days. Medium was changed every 3 to 4
days. Before the experiments, the MDM were detached
from the surface using accutase and seeded into 96-well
plates at 2 × 10
5 cells/well, into 12-well plates at 3 ×
10
5 cells/well or into 6-well plates at 2.5 × 10
6 cells/well.
Transmission electron microscopy (TEM)
To determine the time-dependent uptake of particles
RAW264.7 macrophages were grown on Transwell
®
inserts with polycarbonate membranes with 0.4 μm
pores (Corning, Wiesbaden, Germany) and exposed to
particle suspensions at 50 μg/ml (10.4 μg/cm
2). Pieces of
the membrane with the adherent cells were cut out and
fixed in Karnovsky’s fixant containing 2.5% glutaralde-
hyde (w/v) for 15 min. The membranes were washed
with PBS, post-fixed in 1% (w/v) osmium tetroxide for 7
min and dehydrated in a graded series of ethanol (50,
70, 95, and 100%). Afterwards the membranes were
embedded in EPON 812 (Polysciences, Eppelheim, Ger-
many). The blocks were cutted into ultrathin sections
using a UC6 ultramicrotome (Leica, Bensheim, Ger-
many). Images were taken with a Zeiss EM 109T trans-
mission electron microscope (Oberkochen, Germany).
Viability assay
Cell viability was determined in 96-well plates by the
WST-1 assay after treatment with the particles sus-
pended in complete medium at the indicated concentra-
tions for 24 h. The medium was replaced by 100 μl
WST-1 reagent diluted 1:20 (v/v) with HBSS. After
incubation at 37°C and 5% CO2 for 2 h the activity of
mitochondrial dehydrogenases was detected with a
microplate reader (Molecular Devices, Ismaning, Ger-
many) at 450 nm.
Intracellular ROS detection
Macrophages seeded in 96-well plates were treated with
particles suspended in HBSS for 3 h at the doses indi-
cated (Figure 2B). After washing with HBSS, the cells
were loaded with 50 μMH 2DCF-DA for 30 min. Subse-
quently, the cells were washed again with HBSS and the
relative fluorescence units were determined at 485 nm
excitation and 530 nm emission wavelengths using a
fluorescence reader (MWG-Biotech AG, Ebersberg, Ger-
many). Alternatively, the cells were loaded with 50 μM
H2DCF-DA for 30 min prior to the particle incubation
to improve sensitivity (Figure 8). After treatment with
particles for 2.5 h, the cell layer was washed with HBSS
and the relative fluorescence units were detected.
Analysis of arachidonic acid and PGE2/TXB2 liberation
The determination of arachidonic acid and PGE2/TXB2
liberation in macrophages was performed as described
before [17]. Briefly, after labelling with [1-
14C]arachido-
nic acid the cells were treated with particles for the indi-
cated periods of time in medium without FBS. The
cellular lipids were extracted with a mixture of chloro-
form, methanol and 0.2% formic acid in water according
to a modified procedure originally described by Bligh
and Dyer [64]. The organic phase was collected, dried
under nitrogen, and dissolved with 100 μl chloroform.
The extract was spotted onto 0.25 mm silica gel HPTLC
plates (Macherey-Nagel, Düren, Germany) and separated
by thin-layer chromatography using the solvent system
of ethyl acetate : iso-octane : H2O : acetic acid at
10:5:10:2 (v:v:v:v). The location of [
14C]-labelled arachi-
donic acid and its metabolites was visualized and quan-
tified using the phosphoimager system Cyclone
® Plus
equipped with the software OptiQuant Acquisition and
Analysis (Perkin Elmer, Rodgau-Jügesheim, Germany).
To identify the spots of free arachidonic acid and its
metabolites, non-radioactive standards were run in the
same solvent system and visualized by exposing the
plates to 10% phosphomolybdic acid in ethanol. Since
PGE2 and TXB2 showed equal retention factor (Rf)
values under these conditions, these metabolites were
quantified as a single spot.
Detection of 8-isoprostane
After treatment of cells the medium was collected, cen-
trifuged for 5 min at 4°C and 13,000 × g to remove cell
debris and stored at -80°C until analysis. 8-isoprostane
was analyzed by a competitive enzyme immunoassay
(EIA) according to the instructions of the manufacturer
(Cayman, distributed by Biozol, Eching, Germany).
Western blotting
Cells were harvested, washed twice with PBS and lysed
for 20 min at 4°C in 75 μl RIPA lysis buffer (150 mM
NaCl, 50 mM Tris-HCl pH 7.4, 5 mM EDTA, 1% (v/v)
NP-40, 2 μg/ml leupeptin, 2 μg/ml aprotinine, 1 mM
PMSF). For the detection of phosphorylated proteins,
the lysis buffer additionally contained phosphatase
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many). The cell lysates were centrifuged at 12,000 g for
5 min at 4°C and the protein contents of the superna-
tants were measured with the BCA assay using BSA as a
standard (Perbio, Bonn, Germany). Equivalent amounts
of protein were loaded on a 10% sodium dodecyl sul-
phate (SDS)-polyacrylamide gel. After electrophoresis,
the proteins were transferred to an Immobilon-FL or
Immobilon-P PVDF membrane (Millipore, Eschborn,
Germany). The membranes were blocked with 5% (w/v)
non-fat dry milk in Tris-buffered saline (TBS) for 1 h
and then incubated overnight at 4°C with the appropri-
ate primary antibody in 5% non-fat dry milk in TBS
containing 0.1% Tween20 (TBS-T). After washing, the
membranes were either incubated with a secondary anti-
body coupled with horseradish peroxidase for detection
with ECL reagents or to IRDye800 or Alexa680 coupled
secondary antibodies for detection with the Odyssey
Infrared Imaging System (LICOR Biosciences, Bad Hom-
burg, Germany). The procedures for detection with ECL
and the Odyssey method were performed in accordance
with the manufacturer’s instructions.
Statistical analysis
Values are reported as mean ± standard error of the
mean (s.e.m.) of several independent experiments as
indicated in the legends. Statistical analysis was per-
formed using Student’s t t e s t .V a l u e so fp<0 . 0 5w e r e
considered statistically significant.
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